Expression of human cytochrome P450 1A1 in DNA repair deficient and proficient human fibroblasts stably transformed with an inducible expression vector.
Cytochromes P450 catalyze the bioactivation of many carcinogens. In particular, cytochrome P450 1A1 (CYP1A1) catalyzes the conversion of polycyclic aromatic hydrocarbons, such as benzo[a]pyrene, into potent mutagenic agents. Human skin fibroblasts, both DNA repair deficient (xeroderma pigmentosum group A: XPA) and DNA repair normal have been co-transformed with a chimeric gene construct containing human CYP1A1 coding sequences controlled by the cadmium (Cd) ion inducible mouse metallothionein-I promoter and pRSV-NEO, a dominant selectable marker for G418 resistance. Individual G418 resistant colonies were cloned and analyzed for Cd inducible CYP1A1 activity. Six clones of DNA repair deficient cells and five clones of DNA repair proficient cells have been isolated which express Cd inducible CYP1A1. Benzo[a]pyrene-trans-7,8-diol (BPD) is cytotoxic in Cd induced CYP1A1 expressing cells. The cytotoxicity can be inhibited by 10 microM alpha-napthoflavone. Differential cytotoxicity between the DNA repair deficient and proficient CYP1A1 expressing transformants is observed. BPD is cytotoxic to Cd induced CYP1A1 expressing XPA cells at > 10-fold lower doses than it is to Cd induced CYP1A1 expressing DNA repair normal cells. These data indicate that BPD is metabolized to a DNA damaging agent by induced CYP1A1. In contrast, benzo[a]pyrene-trans-7,8-diol-9,10-epoxide added to the media is only slightly more cytotoxic to DNA repair deficient than to proficient cells regardless of CYP1A1 expression. These studies demonstrate the usefulness of the CYP1A1 transformed fibroblasts in examining the cytotoxic effects of benzo[a]pyrene metabolites and suggest the future usefulness in examining the toxic effects of polycyclic aromatic hydrocarbons and other xenobiotics bioactivated by CYP1A1.
States
J C
JC
Center for Molecular Biology, Wayne State University, Detroit, MI 48201.
Quan
T
T
Hines
R N
RN
Novak
R F
RF
Runge-Morris
M
M
D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / Q000378:metabolism / Q000493:pharmacokinetics; D000818:Animals; D001483:Base Sequence; D001564:Benzo(a)pyrene / Q000378:metabolism / Q000493:pharmacokinetics; D001571:Benzoflavones / Q000494:pharmacology; D001711:Biotransformation; D002104:Cadmium / Q000494:pharmacology; D019187:Cadmium Compounds; D002678:Chimera / Q000235:genetics; D003577:Cytochrome P-450 Enzyme System / Q000172:deficiency / Q000235:genetics* / Q000502:physiology; D004260:DNA Repair / Q000502:physiology*; D004790:Enzyme Induction; D005347:Fibroblasts / Q000187:drug effects / Q000502:physiology*; D015971:Gene Expression Regulation, Enzymologic / Q000235:genetics*; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D007527:Isoenzymes / Q000172:deficiency / Q000235:genetics* / Q000502:physiology; D051379:Mice; D008969:Molecular Sequence Data; D010957:Plasmids; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013431:Sulfates; D014162:Transfection; D014170:Transformation, Genetic / Q000235:genetics*; D014983:Xeroderma Pigmentosum / Q000201:enzymology / Q000473:pathology
D001571:Benzoflavones; D019187:Cadmium Compounds; D007527:Isoenzymes; D012333:RNA, Messenger; D013431:Sulfates; D002104:Cadmium; D001564:Benzo(a)pyrene; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; C011512:alpha-naphthoflavone; D003577:Cytochrome P-450 Enzyme System; C037123:cadmium sulfate